May 16, 2024 / 01:00PM GMT
Operator
Good afternoon, and welcome to the Celadon Pharmaceuticals Plc full year results investor presentation. (Operator instructions) Before we begin, I would like to submit the following pole and I would now like to hand over to CEO, James Short. Good afternoon to you.
James Short - Celadon Pharmaceuticals Plc - co-founder & CEO
Good afternoon, thank you. Thank you, everybody, for joining us today. Some new ones and some rooms that have been supportive over the years. Hopefully, at the end of this presentation, we can make a lot more clearer of the success that we've had through the past five years. I'm also joined by Jonathan Turner, our CFO, who will go through a number of the slides.
What I'd like to do is I always tend to start with this slide and how and the idea is that we tried to reiterate the Celadon is a pharmaceutical company, the operates using cannabinoids, it is not a cannabis company and there are completely fundamental differences of our set the business up. The cannabis adult recreational market is one market, but we are in the
Full Year 2023 Celadon Pharmaceuticals PLC Earnings Call Transcript
May 17, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers